nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A5—Gefitinib—lung cancer	0.0441	0.0615	CbGbCtD
Praziquantel—CYP3A5—Teniposide—lung cancer	0.0428	0.0597	CbGbCtD
Praziquantel—CYP2C19—Gefitinib—lung cancer	0.0356	0.0496	CbGbCtD
Praziquantel—CYP2C19—Teniposide—lung cancer	0.0345	0.0481	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0318	0.0444	CbGbCtD
Praziquantel—CYP3A7—Paclitaxel—lung cancer	0.0318	0.0444	CbGbCtD
Praziquantel—CYP3A7—Irinotecan—lung cancer	0.0314	0.0438	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0314	0.0438	CbGbCtD
Praziquantel—CYP2D6—Gefitinib—lung cancer	0.0271	0.0377	CbGbCtD
Praziquantel—CYP3A5—Crizotinib—lung cancer	0.0271	0.0377	CbGbCtD
Praziquantel—CYP3A5—Erlotinib—lung cancer	0.0261	0.0364	CbGbCtD
Praziquantel—CYP3A5—Paclitaxel—lung cancer	0.0239	0.0333	CbGbCtD
Praziquantel—CYP3A5—Irinotecan—lung cancer	0.0236	0.0329	CbGbCtD
Praziquantel—CYP3A7—Docetaxel—lung cancer	0.023	0.0321	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.023	0.0321	CbGbCtD
Praziquantel—CYP2D6—Vinorelbine—lung cancer	0.0209	0.0291	CbGbCtD
Praziquantel—CYP1A2—Erlotinib—lung cancer	0.0194	0.0271	CbGbCtD
Praziquantel—CYP3A5—Etoposide—lung cancer	0.0189	0.0263	CbGbCtD
Praziquantel—CYP3A4—Topotecan—lung cancer	0.0188	0.0262	CbGbCtD
Praziquantel—CYP3A5—Docetaxel—lung cancer	0.0173	0.0241	CbGbCtD
Praziquantel—CYP3A4—Gefitinib—lung cancer	0.0172	0.024	CbGbCtD
Praziquantel—CYP3A4—Teniposide—lung cancer	0.0167	0.0233	CbGbCtD
Praziquantel—CYP2D6—Erlotinib—lung cancer	0.016	0.0223	CbGbCtD
Praziquantel—CYP1A2—Etoposide—lung cancer	0.0141	0.0196	CbGbCtD
Praziquantel—CYP3A4—Vinorelbine—lung cancer	0.0133	0.0185	CbGbCtD
Praziquantel—CYP2D6—Vinblastine—lung cancer	0.0129	0.0179	CbGbCtD
Praziquantel—CYP3A4—Crizotinib—lung cancer	0.0105	0.0147	CbGbCtD
Praziquantel—CYP3A4—Erlotinib—lung cancer	0.0102	0.0142	CbGbCtD
Praziquantel—CYP3A4—Paclitaxel—lung cancer	0.00932	0.013	CbGbCtD
Praziquantel—CYP3A4—Irinotecan—lung cancer	0.00919	0.0128	CbGbCtD
Praziquantel—CYP3A4—Vinblastine—lung cancer	0.00817	0.0114	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—lung cancer	0.0079	0.011	CbGbCtD
Praziquantel—CYP3A4—Etoposide—lung cancer	0.00736	0.0103	CbGbCtD
Praziquantel—CYP3A4—Docetaxel—lung cancer	0.00674	0.00939	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—lung cancer	0.00502	0.007	CbGbCtD
Praziquantel—Discomfort—Gemcitabine—lung cancer	0.000355	0.0022	CcSEcCtD
Praziquantel—Malaise—Cisplatin—lung cancer	0.000354	0.0022	CcSEcCtD
Praziquantel—Pruritus—Topotecan—lung cancer	0.000354	0.0022	CcSEcCtD
Praziquantel—Feeling abnormal—Vinorelbine—lung cancer	0.000353	0.00219	CcSEcCtD
Praziquantel—Diarrhoea—Vinblastine—lung cancer	0.000353	0.00219	CcSEcCtD
Praziquantel—Pruritus—Erlotinib—lung cancer	0.000351	0.00218	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vinorelbine—lung cancer	0.00035	0.00218	CcSEcCtD
Praziquantel—Nervous system disorder—Irinotecan—lung cancer	0.000347	0.00215	CcSEcCtD
Praziquantel—Diarrhoea—Topotecan—lung cancer	0.000343	0.00213	CcSEcCtD
Praziquantel—Dizziness—Vinblastine—lung cancer	0.000341	0.00212	CcSEcCtD
Praziquantel—Convulsion—Cisplatin—lung cancer	0.000341	0.00212	CcSEcCtD
Praziquantel—Urticaria—Vinorelbine—lung cancer	0.00034	0.00212	CcSEcCtD
Praziquantel—Diarrhoea—Erlotinib—lung cancer	0.000339	0.00211	CcSEcCtD
Praziquantel—Abdominal pain—Vinorelbine—lung cancer	0.000339	0.00211	CcSEcCtD
Praziquantel—Body temperature increased—Vinorelbine—lung cancer	0.000339	0.00211	CcSEcCtD
Praziquantel—Nervous system disorder—Gemcitabine—lung cancer	0.000338	0.0021	CcSEcCtD
Praziquantel—Anorexia—Irinotecan—lung cancer	0.000337	0.00209	CcSEcCtD
Praziquantel—Myalgia—Cisplatin—lung cancer	0.000335	0.00208	CcSEcCtD
Praziquantel—Skin disorder—Gemcitabine—lung cancer	0.000334	0.00208	CcSEcCtD
Praziquantel—Ill-defined disorder—Etoposide—lung cancer	0.000334	0.00208	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000332	0.00207	CcSEcCtD
Praziquantel—Dizziness—Topotecan—lung cancer	0.000331	0.00206	CcSEcCtD
Praziquantel—Discomfort—Cisplatin—lung cancer	0.000331	0.00206	CcSEcCtD
Praziquantel—Anorexia—Gemcitabine—lung cancer	0.000328	0.00204	CcSEcCtD
Praziquantel—Vomiting—Vinblastine—lung cancer	0.000328	0.00204	CcSEcCtD
Praziquantel—Dizziness—Erlotinib—lung cancer	0.000328	0.00204	CcSEcCtD
Praziquantel—Ill-defined disorder—Paclitaxel—lung cancer	0.000328	0.00204	CcSEcCtD
Praziquantel—Malaise—Etoposide—lung cancer	0.000325	0.00202	CcSEcCtD
Praziquantel—Vertigo—Etoposide—lung cancer	0.000324	0.00201	CcSEcCtD
Praziquantel—Headache—Vinblastine—lung cancer	0.000323	0.00201	CcSEcCtD
Praziquantel—Cardiac disorder—Docetaxel—lung cancer	0.000319	0.00198	CcSEcCtD
Praziquantel—Vomiting—Topotecan—lung cancer	0.000318	0.00198	CcSEcCtD
Praziquantel—Malaise—Paclitaxel—lung cancer	0.000318	0.00198	CcSEcCtD
Praziquantel—Vertigo—Paclitaxel—lung cancer	0.000317	0.00197	CcSEcCtD
Praziquantel—Rash—Topotecan—lung cancer	0.000316	0.00196	CcSEcCtD
Praziquantel—Hypersensitivity—Vinorelbine—lung cancer	0.000316	0.00196	CcSEcCtD
Praziquantel—Dermatitis—Topotecan—lung cancer	0.000315	0.00196	CcSEcCtD
Praziquantel—Vomiting—Erlotinib—lung cancer	0.000315	0.00196	CcSEcCtD
Praziquantel—Nervous system disorder—Cisplatin—lung cancer	0.000315	0.00196	CcSEcCtD
Praziquantel—Somnolence—Irinotecan—lung cancer	0.000314	0.00195	CcSEcCtD
Praziquantel—Headache—Topotecan—lung cancer	0.000314	0.00195	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000314	0.00195	CcSEcCtD
Praziquantel—Rash—Erlotinib—lung cancer	0.000312	0.00194	CcSEcCtD
Praziquantel—Dermatitis—Erlotinib—lung cancer	0.000312	0.00194	CcSEcCtD
Praziquantel—Convulsion—Etoposide—lung cancer	0.000312	0.00194	CcSEcCtD
Praziquantel—Skin disorder—Cisplatin—lung cancer	0.000312	0.00194	CcSEcCtD
Praziquantel—Immune system disorder—Docetaxel—lung cancer	0.000311	0.00193	CcSEcCtD
Praziquantel—Headache—Erlotinib—lung cancer	0.00031	0.00193	CcSEcCtD
Praziquantel—Asthenia—Vinorelbine—lung cancer	0.000307	0.00191	CcSEcCtD
Praziquantel—Decreased appetite—Irinotecan—lung cancer	0.000307	0.00191	CcSEcCtD
Praziquantel—Arrhythmia—Docetaxel—lung cancer	0.000307	0.00191	CcSEcCtD
Praziquantel—Eosinophilia—Methotrexate—lung cancer	0.000307	0.00191	CcSEcCtD
Praziquantel—Nausea—Vinblastine—lung cancer	0.000306	0.0019	CcSEcCtD
Praziquantel—Somnolence—Gemcitabine—lung cancer	0.000306	0.0019	CcSEcCtD
Praziquantel—Convulsion—Paclitaxel—lung cancer	0.000306	0.0019	CcSEcCtD
Praziquantel—Anorexia—Cisplatin—lung cancer	0.000306	0.0019	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Irinotecan—lung cancer	0.000305	0.0019	CcSEcCtD
Praziquantel—Fatigue—Irinotecan—lung cancer	0.000305	0.00189	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000304	0.00189	CcSEcCtD
Praziquantel—Pruritus—Vinorelbine—lung cancer	0.000303	0.00188	CcSEcCtD
Praziquantel—Discomfort—Etoposide—lung cancer	0.000303	0.00188	CcSEcCtD
Praziquantel—Myalgia—Paclitaxel—lung cancer	0.000301	0.00187	CcSEcCtD
Praziquantel—Decreased appetite—Gemcitabine—lung cancer	0.000299	0.00186	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000299	0.00186	CcSEcCtD
Praziquantel—Nausea—Topotecan—lung cancer	0.000297	0.00185	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000297	0.00185	CcSEcCtD
Praziquantel—Discomfort—Paclitaxel—lung cancer	0.000297	0.00185	CcSEcCtD
Praziquantel—Abdominal discomfort—Methotrexate—lung cancer	0.000297	0.00184	CcSEcCtD
Praziquantel—Fatigue—Gemcitabine—lung cancer	0.000297	0.00184	CcSEcCtD
Praziquantel—Nausea—Erlotinib—lung cancer	0.000294	0.00183	CcSEcCtD
Praziquantel—Diarrhoea—Vinorelbine—lung cancer	0.000293	0.00182	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000292	0.00182	CcSEcCtD
Praziquantel—Feeling abnormal—Irinotecan—lung cancer	0.000291	0.00181	CcSEcCtD
Praziquantel—Gastrointestinal pain—Irinotecan—lung cancer	0.000289	0.0018	CcSEcCtD
Praziquantel—Skin disorder—Etoposide—lung cancer	0.000285	0.00177	CcSEcCtD
Praziquantel—Feeling abnormal—Gemcitabine—lung cancer	0.000284	0.00176	CcSEcCtD
Praziquantel—Dizziness—Vinorelbine—lung cancer	0.000283	0.00176	CcSEcCtD
Praziquantel—Nervous system disorder—Paclitaxel—lung cancer	0.000283	0.00176	CcSEcCtD
Praziquantel—Anorexia—Etoposide—lung cancer	0.00028	0.00174	CcSEcCtD
Praziquantel—Skin disorder—Paclitaxel—lung cancer	0.00028	0.00174	CcSEcCtD
Praziquantel—Abdominal pain—Irinotecan—lung cancer	0.000279	0.00174	CcSEcCtD
Praziquantel—Body temperature increased—Irinotecan—lung cancer	0.000279	0.00174	CcSEcCtD
Praziquantel—Decreased appetite—Cisplatin—lung cancer	0.000279	0.00173	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Cisplatin—lung cancer	0.000277	0.00172	CcSEcCtD
Praziquantel—Drowsiness—Methotrexate—lung cancer	0.000276	0.00172	CcSEcCtD
Praziquantel—Anorexia—Paclitaxel—lung cancer	0.000275	0.00171	CcSEcCtD
Praziquantel—Vomiting—Vinorelbine—lung cancer	0.000272	0.00169	CcSEcCtD
Praziquantel—Body temperature increased—Gemcitabine—lung cancer	0.000272	0.00169	CcSEcCtD
Praziquantel—Rash—Vinorelbine—lung cancer	0.00027	0.00168	CcSEcCtD
Praziquantel—Dermatitis—Vinorelbine—lung cancer	0.00027	0.00168	CcSEcCtD
Praziquantel—Headache—Vinorelbine—lung cancer	0.000268	0.00167	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—lung cancer	0.000265	0.00165	CcSEcCtD
Praziquantel—Feeling abnormal—Cisplatin—lung cancer	0.000264	0.00164	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000263	0.00163	CcSEcCtD
Praziquantel—Somnolence—Etoposide—lung cancer	0.000261	0.00162	CcSEcCtD
Praziquantel—Hypersensitivity—Irinotecan—lung cancer	0.00026	0.00162	CcSEcCtD
Praziquantel—Convulsion—Docetaxel—lung cancer	0.000259	0.00161	CcSEcCtD
Praziquantel—Somnolence—Paclitaxel—lung cancer	0.000256	0.00159	CcSEcCtD
Praziquantel—Decreased appetite—Etoposide—lung cancer	0.000255	0.00159	CcSEcCtD
Praziquantel—Myalgia—Docetaxel—lung cancer	0.000255	0.00158	CcSEcCtD
Praziquantel—Nausea—Vinorelbine—lung cancer	0.000254	0.00158	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Etoposide—lung cancer	0.000254	0.00158	CcSEcCtD
Praziquantel—Body temperature increased—Cisplatin—lung cancer	0.000254	0.00158	CcSEcCtD
Praziquantel—Asthenia—Irinotecan—lung cancer	0.000254	0.00158	CcSEcCtD
Praziquantel—Fatigue—Etoposide—lung cancer	0.000253	0.00158	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000253	0.00157	CcSEcCtD
Praziquantel—Decreased appetite—Paclitaxel—lung cancer	0.000251	0.00156	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000249	0.00155	CcSEcCtD
Praziquantel—Fatigue—Paclitaxel—lung cancer	0.000248	0.00154	CcSEcCtD
Praziquantel—Asthenia—Gemcitabine—lung cancer	0.000247	0.00153	CcSEcCtD
Praziquantel—Pruritus—Gemcitabine—lung cancer	0.000244	0.00151	CcSEcCtD
Praziquantel—Feeling abnormal—Etoposide—lung cancer	0.000242	0.00151	CcSEcCtD
Praziquantel—Diarrhoea—Irinotecan—lung cancer	0.000242	0.0015	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—lung cancer	0.00024	0.00149	CcSEcCtD
Praziquantel—Nervous system disorder—Docetaxel—lung cancer	0.00024	0.00149	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—lung cancer	0.000239	0.00149	CcSEcCtD
Praziquantel—Feeling abnormal—Paclitaxel—lung cancer	0.000237	0.00148	CcSEcCtD
Praziquantel—Skin disorder—Docetaxel—lung cancer	0.000237	0.00147	CcSEcCtD
Praziquantel—Hypersensitivity—Cisplatin—lung cancer	0.000236	0.00147	CcSEcCtD
Praziquantel—Gastrointestinal pain—Paclitaxel—lung cancer	0.000236	0.00146	CcSEcCtD
Praziquantel—Diarrhoea—Gemcitabine—lung cancer	0.000235	0.00146	CcSEcCtD
Praziquantel—Dizziness—Irinotecan—lung cancer	0.000234	0.00145	CcSEcCtD
Praziquantel—Urticaria—Etoposide—lung cancer	0.000233	0.00145	CcSEcCtD
Praziquantel—Anorexia—Docetaxel—lung cancer	0.000233	0.00145	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—lung cancer	0.000232	0.00144	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—lung cancer	0.000232	0.00144	CcSEcCtD
Praziquantel—Asthenia—Cisplatin—lung cancer	0.00023	0.00143	CcSEcCtD
Praziquantel—Cardiac disorder—Methotrexate—lung cancer	0.00023	0.00143	CcSEcCtD
Praziquantel—Urticaria—Paclitaxel—lung cancer	0.000229	0.00142	CcSEcCtD
Praziquantel—Body temperature increased—Paclitaxel—lung cancer	0.000228	0.00142	CcSEcCtD
Praziquantel—Abdominal pain—Paclitaxel—lung cancer	0.000228	0.00142	CcSEcCtD
Praziquantel—Vomiting—Irinotecan—lung cancer	0.000225	0.0014	CcSEcCtD
Praziquantel—Immune system disorder—Methotrexate—lung cancer	0.000224	0.00139	CcSEcCtD
Praziquantel—Rash—Irinotecan—lung cancer	0.000223	0.00138	CcSEcCtD
Praziquantel—Dermatitis—Irinotecan—lung cancer	0.000223	0.00138	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000223	0.00138	CcSEcCtD
Praziquantel—Headache—Irinotecan—lung cancer	0.000221	0.00138	CcSEcCtD
Praziquantel—Diarrhoea—Cisplatin—lung cancer	0.00022	0.00136	CcSEcCtD
Praziquantel—Vomiting—Gemcitabine—lung cancer	0.000219	0.00136	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—lung cancer	0.000218	0.00136	CcSEcCtD
Praziquantel—Somnolence—Docetaxel—lung cancer	0.000217	0.00135	CcSEcCtD
Praziquantel—Rash—Gemcitabine—lung cancer	0.000217	0.00135	CcSEcCtD
Praziquantel—Dermatitis—Gemcitabine—lung cancer	0.000217	0.00135	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—lung cancer	0.000217	0.00135	CcSEcCtD
Praziquantel—Headache—Gemcitabine—lung cancer	0.000216	0.00134	CcSEcCtD
Praziquantel—Decreased appetite—Docetaxel—lung cancer	0.000212	0.00132	CcSEcCtD
Praziquantel—Hypersensitivity—Paclitaxel—lung cancer	0.000212	0.00132	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Docetaxel—lung cancer	0.000211	0.00131	CcSEcCtD
Praziquantel—Asthenia—Etoposide—lung cancer	0.000211	0.00131	CcSEcCtD
Praziquantel—Fatigue—Docetaxel—lung cancer	0.000211	0.00131	CcSEcCtD
Praziquantel—Nausea—Irinotecan—lung cancer	0.00021	0.0013	CcSEcCtD
Praziquantel—Pruritus—Etoposide—lung cancer	0.000208	0.00129	CcSEcCtD
Praziquantel—Asthenia—Paclitaxel—lung cancer	0.000207	0.00129	CcSEcCtD
Praziquantel—Nausea—Gemcitabine—lung cancer	0.000204	0.00127	CcSEcCtD
Praziquantel—Vomiting—Cisplatin—lung cancer	0.000204	0.00127	CcSEcCtD
Praziquantel—Pruritus—Paclitaxel—lung cancer	0.000204	0.00127	CcSEcCtD
Praziquantel—Rash—Cisplatin—lung cancer	0.000202	0.00126	CcSEcCtD
Praziquantel—Dermatitis—Cisplatin—lung cancer	0.000202	0.00126	CcSEcCtD
Praziquantel—Feeling abnormal—Docetaxel—lung cancer	0.000201	0.00125	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—lung cancer	0.000201	0.00125	CcSEcCtD
Praziquantel—Ill-defined disorder—Methotrexate—lung cancer	0.0002	0.00124	CcSEcCtD
Praziquantel—Gastrointestinal pain—Docetaxel—lung cancer	0.0002	0.00124	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—lung cancer	0.000199	0.00124	CcSEcCtD
Praziquantel—Diarrhoea—Paclitaxel—lung cancer	0.000197	0.00123	CcSEcCtD
Praziquantel—Malaise—Methotrexate—lung cancer	0.000195	0.00121	CcSEcCtD
Praziquantel—Dizziness—Etoposide—lung cancer	0.000194	0.00121	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—lung cancer	0.000194	0.0012	CcSEcCtD
Praziquantel—Vertigo—Methotrexate—lung cancer	0.000194	0.0012	CcSEcCtD
Praziquantel—Abdominal pain—Docetaxel—lung cancer	0.000193	0.0012	CcSEcCtD
Praziquantel—Body temperature increased—Docetaxel—lung cancer	0.000193	0.0012	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—lung cancer	0.000192	0.00119	CcSEcCtD
Praziquantel—Dizziness—Paclitaxel—lung cancer	0.000191	0.00118	CcSEcCtD
Praziquantel—Nausea—Cisplatin—lung cancer	0.000191	0.00118	CcSEcCtD
Praziquantel—Convulsion—Methotrexate—lung cancer	0.000187	0.00116	CcSEcCtD
Praziquantel—Vomiting—Etoposide—lung cancer	0.000187	0.00116	CcSEcCtD
Praziquantel—Rash—Etoposide—lung cancer	0.000185	0.00115	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—lung cancer	0.000185	0.00115	CcSEcCtD
Praziquantel—Headache—Etoposide—lung cancer	0.000184	0.00114	CcSEcCtD
Praziquantel—Myalgia—Methotrexate—lung cancer	0.000184	0.00114	CcSEcCtD
Praziquantel—Vomiting—Paclitaxel—lung cancer	0.000183	0.00114	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000182	0.00113	CcSEcCtD
Praziquantel—Rash—Paclitaxel—lung cancer	0.000182	0.00113	CcSEcCtD
Praziquantel—Dermatitis—Paclitaxel—lung cancer	0.000182	0.00113	CcSEcCtD
Praziquantel—Discomfort—Methotrexate—lung cancer	0.000181	0.00113	CcSEcCtD
Praziquantel—Headache—Paclitaxel—lung cancer	0.000181	0.00112	CcSEcCtD
Praziquantel—Hypersensitivity—Docetaxel—lung cancer	0.00018	0.00112	CcSEcCtD
Praziquantel—Asthenia—Docetaxel—lung cancer	0.000175	0.00109	CcSEcCtD
Praziquantel—Nausea—Etoposide—lung cancer	0.000175	0.00109	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—lung cancer	0.000173	0.00108	CcSEcCtD
Praziquantel—Pruritus—Docetaxel—lung cancer	0.000173	0.00107	CcSEcCtD
Praziquantel—Nervous system disorder—Methotrexate—lung cancer	0.000173	0.00107	CcSEcCtD
Praziquantel—Nausea—Paclitaxel—lung cancer	0.000171	0.00106	CcSEcCtD
Praziquantel—Skin disorder—Methotrexate—lung cancer	0.000171	0.00106	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—lung cancer	0.000168	0.00105	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—lung cancer	0.000168	0.00104	CcSEcCtD
Praziquantel—Anorexia—Methotrexate—lung cancer	0.000168	0.00104	CcSEcCtD
Praziquantel—Diarrhoea—Docetaxel—lung cancer	0.000167	0.00104	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—lung cancer	0.000162	0.00101	CcSEcCtD
Praziquantel—Dizziness—Docetaxel—lung cancer	0.000162	0.001	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00016	0.000997	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—lung cancer	0.000159	0.000988	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000158	0.000982	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—lung cancer	0.000157	0.000977	CcSEcCtD
Praziquantel—Somnolence—Methotrexate—lung cancer	0.000157	0.000973	CcSEcCtD
Praziquantel—Vomiting—Docetaxel—lung cancer	0.000155	0.000965	CcSEcCtD
Praziquantel—Rash—Docetaxel—lung cancer	0.000154	0.000957	CcSEcCtD
Praziquantel—Dermatitis—Docetaxel—lung cancer	0.000154	0.000956	CcSEcCtD
Praziquantel—Decreased appetite—Methotrexate—lung cancer	0.000153	0.000951	CcSEcCtD
Praziquantel—Headache—Docetaxel—lung cancer	0.000153	0.000951	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Methotrexate—lung cancer	0.000152	0.000945	CcSEcCtD
Praziquantel—Fatigue—Methotrexate—lung cancer	0.000152	0.000943	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—lung cancer	0.000149	0.000929	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—lung cancer	0.000148	0.00092	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—lung cancer	0.000145	0.000903	CcSEcCtD
Praziquantel—Nausea—Docetaxel—lung cancer	0.000145	0.000902	CcSEcCtD
Praziquantel—Feeling abnormal—Methotrexate—lung cancer	0.000145	0.000902	CcSEcCtD
Praziquantel—Gastrointestinal pain—Methotrexate—lung cancer	0.000144	0.000895	CcSEcCtD
Praziquantel—Urticaria—Methotrexate—lung cancer	0.00014	0.000869	CcSEcCtD
Praziquantel—Body temperature increased—Methotrexate—lung cancer	0.000139	0.000865	CcSEcCtD
Praziquantel—Abdominal pain—Methotrexate—lung cancer	0.000139	0.000865	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000139	0.000863	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—lung cancer	0.000136	0.000842	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—lung cancer	0.000133	0.000824	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000132	0.000818	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—lung cancer	0.000131	0.000817	CcSEcCtD
Praziquantel—Hypersensitivity—Methotrexate—lung cancer	0.00013	0.000806	CcSEcCtD
Praziquantel—Asthenia—Methotrexate—lung cancer	0.000126	0.000785	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—lung cancer	0.000126	0.000781	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—lung cancer	0.000125	0.000775	CcSEcCtD
Praziquantel—Pruritus—Methotrexate—lung cancer	0.000125	0.000774	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—lung cancer	0.000121	0.000753	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—lung cancer	0.000121	0.000749	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—lung cancer	0.000121	0.000749	CcSEcCtD
Praziquantel—Diarrhoea—Methotrexate—lung cancer	0.00012	0.000749	CcSEcCtD
Praziquantel—Dizziness—Methotrexate—lung cancer	0.000116	0.000724	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—lung cancer	0.000112	0.000698	CcSEcCtD
Praziquantel—Vomiting—Methotrexate—lung cancer	0.000112	0.000696	CcSEcCtD
Praziquantel—Rash—Methotrexate—lung cancer	0.000111	0.00069	CcSEcCtD
Praziquantel—Dermatitis—Methotrexate—lung cancer	0.000111	0.000689	CcSEcCtD
Praziquantel—Headache—Methotrexate—lung cancer	0.00011	0.000686	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—lung cancer	0.000109	0.00068	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—lung cancer	0.000108	0.00067	CcSEcCtD
Praziquantel—Nausea—Methotrexate—lung cancer	0.000105	0.00065	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—lung cancer	0.000104	0.000648	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—lung cancer	0.000101	0.000627	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—lung cancer	9.69e-05	0.000602	CcSEcCtD
Praziquantel—Rash—Doxorubicin—lung cancer	9.61e-05	0.000597	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—lung cancer	9.6e-05	0.000597	CcSEcCtD
Praziquantel—Headache—Doxorubicin—lung cancer	9.55e-05	0.000594	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—lung cancer	9.05e-05	0.000563	CcSEcCtD
Praziquantel—CYP3A7—Metabolism—STK11—lung cancer	1.76e-05	0.000145	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ENO2—lung cancer	1.75e-05	0.000144	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—HPGDS—lung cancer	1.75e-05	0.000144	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—EP300—lung cancer	1.74e-05	0.000143	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP2A7—lung cancer	1.74e-05	0.000143	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.74e-05	0.000143	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—B4GALT5—lung cancer	1.72e-05	0.000142	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTA1—lung cancer	1.71e-05	0.000141	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SDC4—lung cancer	1.71e-05	0.00014	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HSD17B10—lung cancer	1.7e-05	0.00014	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTT1—lung cancer	1.7e-05	0.00014	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCC3—lung cancer	1.7e-05	0.000139	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP2A6—lung cancer	1.68e-05	0.000138	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GCLC—lung cancer	1.68e-05	0.000138	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTA4—lung cancer	1.68e-05	0.000138	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKR1C1—lung cancer	1.64e-05	0.000135	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTA2—lung cancer	1.63e-05	0.000134	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTP1—lung cancer	1.63e-05	0.000134	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—UGT1A1—lung cancer	1.59e-05	0.000131	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ENO1—lung cancer	1.59e-05	0.000131	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CAT—lung cancer	1.59e-05	0.00013	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CKB—lung cancer	1.58e-05	0.00013	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTA1—lung cancer	1.58e-05	0.000129	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCC3—lung cancer	1.56e-05	0.000128	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—RRM1—lung cancer	1.55e-05	0.000128	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTA3—lung cancer	1.55e-05	0.000128	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ABCB1—lung cancer	1.54e-05	0.000127	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GNG11—lung cancer	1.54e-05	0.000126	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.53e-05	0.000126	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—TYMS—lung cancer	1.52e-05	0.000124	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKR1C1—lung cancer	1.51e-05	0.000124	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTM1—lung cancer	1.5e-05	0.000123	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM2—lung cancer	1.49e-05	0.000122	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CNDP2—lung cancer	1.49e-05	0.000122	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—UGT1A1—lung cancer	1.47e-05	0.00012	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALDOA—lung cancer	1.46e-05	0.00012	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—B4GALT5—lung cancer	1.46e-05	0.00012	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTMR3—lung cancer	1.45e-05	0.000119	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP2E1—lung cancer	1.43e-05	0.000117	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTA4—lung cancer	1.42e-05	0.000117	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NCOA3—lung cancer	1.42e-05	0.000117	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP1A1—lung cancer	1.42e-05	0.000117	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GNG11—lung cancer	1.41e-05	0.000116	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NQO1—lung cancer	1.41e-05	0.000116	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PGAM1—lung cancer	1.41e-05	0.000116	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ERCC2—lung cancer	1.41e-05	0.000116	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.4e-05	0.000115	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.39e-05	0.000114	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTA2—lung cancer	1.38e-05	0.000114	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ADCY1—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCG2—lung cancer	1.38e-05	0.000113	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—HPGDS—lung cancer	1.36e-05	0.000111	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ENO2—lung cancer	1.36e-05	0.000111	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.35e-05	0.000111	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALDOA—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP2A7—lung cancer	1.35e-05	0.00011	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTA1—lung cancer	1.34e-05	0.00011	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.33e-05	0.000109	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCC3—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SDC4—lung cancer	1.32e-05	0.000108	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTT1—lung cancer	1.31e-05	0.000108	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NCOA3—lung cancer	1.31e-05	0.000107	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP2A6—lung cancer	1.3e-05	0.000107	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GCLC—lung cancer	1.3e-05	0.000107	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PIK3CA—lung cancer	1.29e-05	0.000106	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKR1C1—lung cancer	1.28e-05	0.000105	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—STK11—lung cancer	1.27e-05	0.000105	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ADCY1—lung cancer	1.27e-05	0.000104	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCG2—lung cancer	1.27e-05	0.000104	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ENO2—lung cancer	1.25e-05	0.000102	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HPGDS—lung cancer	1.25e-05	0.000102	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—UGT1A1—lung cancer	1.24e-05	0.000102	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.24e-05	0.000102	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ENO1—lung cancer	1.23e-05	0.000101	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.23e-05	0.000101	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—APOA1—lung cancer	1.22e-05	0.0001	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.21e-05	9.94e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTT1—lung cancer	1.21e-05	9.92e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—RRM1—lung cancer	1.2e-05	9.84e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA3—lung cancer	1.2e-05	9.84e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GNG11—lung cancer	1.2e-05	9.83e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GCLC—lung cancer	1.2e-05	9.81e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP2A6—lung cancer	1.2e-05	9.81e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.19e-05	9.78e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTP1—lung cancer	1.18e-05	9.67e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CAT—lung cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALDOA—lung cancer	1.14e-05	9.36e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ENO1—lung cancer	1.13e-05	9.3e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—B4GALT5—lung cancer	1.13e-05	9.25e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ABCB1—lung cancer	1.12e-05	9.16e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CG—lung cancer	1.11e-05	9.13e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NCOA3—lung cancer	1.11e-05	9.09e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP2E1—lung cancer	1.1e-05	9.07e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA4—lung cancer	1.1e-05	9e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—TYMS—lung cancer	1.1e-05	8.99e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NQO1—lung cancer	1.09e-05	8.97e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.09e-05	8.93e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTM1—lung cancer	1.08e-05	8.89e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ADCY1—lung cancer	1.08e-05	8.84e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCG2—lung cancer	1.08e-05	8.84e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.07e-05	8.78e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA2—lung cancer	1.07e-05	8.77e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.06e-05	8.7e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—POMC—lung cancer	1.06e-05	8.69e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HPGDS—lung cancer	1.06e-05	8.67e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ENO2—lung cancer	1.06e-05	8.67e-05	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—AKT1—lung cancer	1.05e-05	8.65e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.05e-05	8.61e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.04e-05	8.5e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CREBBP—lung cancer	1.03e-05	8.47e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTA1—lung cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP1A1—lung cancer	1.03e-05	8.43e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTT1—lung cancer	1.02e-05	8.41e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCC3—lung cancer	1.02e-05	8.37e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ERCC2—lung cancer	1.02e-05	8.36e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP2E1—lung cancer	1.02e-05	8.34e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP2A6—lung cancer	1.01e-05	8.31e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GCLC—lung cancer	1.01e-05	8.31e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.01e-05	8.28e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NQO1—lung cancer	1e-05	8.25e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKR1C1—lung cancer	9.87e-06	8.1e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—STK11—lung cancer	9.85e-06	8.08e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CD—lung cancer	9.78e-06	8.03e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALB—lung cancer	9.66e-06	7.92e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ENO1—lung cancer	9.6e-06	7.88e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—UGT1A1—lung cancer	9.59e-06	7.87e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.56e-06	7.85e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.44e-06	7.75e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.24e-06	7.59e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GNG11—lung cancer	9.24e-06	7.59e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTP1—lung cancer	9.11e-06	7.48e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—STK11—lung cancer	9.06e-06	7.43e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CAT—lung cancer	8.87e-06	7.28e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.82e-06	7.23e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—APOA1—lung cancer	8.81e-06	7.23e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALDOA—lung cancer	8.8e-06	7.22e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCB1—lung cancer	8.63e-06	7.08e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP2E1—lung cancer	8.61e-06	7.07e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NCOA3—lung cancer	8.54e-06	7.01e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CB—lung cancer	8.52e-06	7e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NQO1—lung cancer	8.51e-06	6.99e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—TYMS—lung cancer	8.47e-06	6.95e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTGS2—lung cancer	8.45e-06	6.93e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTP1—lung cancer	8.38e-06	6.88e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTM1—lung cancer	8.37e-06	6.87e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.34e-06	6.84e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCG2—lung cancer	8.31e-06	6.82e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ADCY1—lung cancer	8.31e-06	6.82e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.26e-06	6.78e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CAT—lung cancer	8.16e-06	6.69e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ENO2—lung cancer	8.15e-06	6.69e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HPGDS—lung cancer	8.15e-06	6.69e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.1e-06	6.65e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CG—lung cancer	8.04e-06	6.6e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1A1—lung cancer	7.94e-06	6.51e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCB1—lung cancer	7.93e-06	6.51e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTT1—lung cancer	7.91e-06	6.49e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ERCC2—lung cancer	7.87e-06	6.46e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GCLC—lung cancer	7.81e-06	6.41e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP2A6—lung cancer	7.81e-06	6.41e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—TYMS—lung cancer	7.79e-06	6.39e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTM1—lung cancer	7.7e-06	6.32e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—STK11—lung cancer	7.67e-06	6.3e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—POMC—lung cancer	7.66e-06	6.28e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CREBBP—lung cancer	7.46e-06	6.12e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ENO1—lung cancer	7.41e-06	6.08e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTEN—lung cancer	7.37e-06	6.05e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1A1—lung cancer	7.3e-06	5.99e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ERCC2—lung cancer	7.24e-06	5.94e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.2e-06	5.91e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTP1—lung cancer	7.1e-06	5.83e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CD—lung cancer	7.07e-06	5.8e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—EP300—lung cancer	7.03e-06	5.77e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALB—lung cancer	6.98e-06	5.73e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CAT—lung cancer	6.91e-06	5.67e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.87e-06	5.64e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—APOA1—lung cancer	6.81e-06	5.59e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCB1—lung cancer	6.72e-06	5.52e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP2E1—lung cancer	6.64e-06	5.45e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—TYMS—lung cancer	6.6e-06	5.42e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NQO1—lung cancer	6.57e-06	5.39e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTM1—lung cancer	6.52e-06	5.35e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.52e-06	5.35e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—APOA1—lung cancer	6.26e-06	5.14e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CG—lung cancer	6.22e-06	5.1e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP1A1—lung cancer	6.18e-06	5.08e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CB—lung cancer	6.16e-06	5.06e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ERCC2—lung cancer	6.13e-06	5.03e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTGS2—lung cancer	6.11e-06	5.01e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—STK11—lung cancer	5.92e-06	4.86e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—POMC—lung cancer	5.92e-06	4.86e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CREBBP—lung cancer	5.76e-06	4.73e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CG—lung cancer	5.72e-06	4.69e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTP1—lung cancer	5.48e-06	4.5e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CD—lung cancer	5.47e-06	4.49e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—POMC—lung cancer	5.44e-06	4.47e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALB—lung cancer	5.4e-06	4.43e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CAT—lung cancer	5.33e-06	4.38e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTEN—lung cancer	5.32e-06	4.37e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—APOA1—lung cancer	5.31e-06	4.35e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CREBBP—lung cancer	5.3e-06	4.35e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CA—lung cancer	5.2e-06	4.27e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCB1—lung cancer	5.19e-06	4.26e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—TYMS—lung cancer	5.09e-06	4.18e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.08e-06	4.17e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—EP300—lung cancer	5.08e-06	4.17e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM1—lung cancer	5.04e-06	4.13e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CD—lung cancer	5.03e-06	4.13e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALB—lung cancer	4.96e-06	4.07e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CG—lung cancer	4.84e-06	3.98e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1A1—lung cancer	4.77e-06	3.92e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CB—lung cancer	4.76e-06	3.91e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ERCC2—lung cancer	4.73e-06	3.89e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTGS2—lung cancer	4.72e-06	3.87e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—POMC—lung cancer	4.61e-06	3.78e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CREBBP—lung cancer	4.49e-06	3.69e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CB—lung cancer	4.38e-06	3.6e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTGS2—lung cancer	4.34e-06	3.56e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CD—lung cancer	4.26e-06	3.5e-05	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—AKT1—lung cancer	4.25e-06	3.48e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALB—lung cancer	4.2e-06	3.45e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTEN—lung cancer	4.12e-06	3.38e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—APOA1—lung cancer	4.1e-06	3.36e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—EP300—lung cancer	3.93e-06	3.22e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTEN—lung cancer	3.79e-06	3.11e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CA—lung cancer	3.76e-06	3.08e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CG—lung cancer	3.74e-06	3.07e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CB—lung cancer	3.71e-06	3.05e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTGS2—lung cancer	3.68e-06	3.02e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—EP300—lung cancer	3.61e-06	2.96e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—POMC—lung cancer	3.56e-06	2.92e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CREBBP—lung cancer	3.47e-06	2.84e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CD—lung cancer	3.29e-06	2.7e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALB—lung cancer	3.24e-06	2.66e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTEN—lung cancer	3.21e-06	2.63e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—AKT1—lung cancer	3.07e-06	2.52e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—EP300—lung cancer	3.06e-06	2.51e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CA—lung cancer	2.9e-06	2.38e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CB—lung cancer	2.86e-06	2.35e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTGS2—lung cancer	2.84e-06	2.33e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CA—lung cancer	2.67e-06	2.19e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTEN—lung cancer	2.48e-06	2.03e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—AKT1—lung cancer	2.37e-06	1.95e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—EP300—lung cancer	2.36e-06	1.94e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CA—lung cancer	2.26e-06	1.86e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—AKT1—lung cancer	2.18e-06	1.79e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—AKT1—lung cancer	1.85e-06	1.52e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CA—lung cancer	1.75e-06	1.43e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—AKT1—lung cancer	1.43e-06	1.17e-05	CbGpPWpGaD
